$0.5470
-0.003-0.55%
Last update: Nov 4, 6:21 PM
Citius Oncology Inc
CTORNASDAQ
The average analyst price target for Citius Oncology is $6, 943.5% above the current price. Of 2 analysts, 2 rate it Buy. The latest change came on Sep 23, 2025, when Maxim Group upgraded Citius Oncology from Hold to Buy with a $6 price target.
Price Target Range — 3 Quarters
Analyst Consensus — 2 Analysts
Rating Trend — Last 9 Months
